Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,994
New position
Shares Held
10
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#4,571
of 4,601 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFS Advisors, LLC holds $238,324 across 8 Drug Manufacturers - General names. LLY ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
597 | $76,714 | |
| 2 | ABBV |
AbbVie Inc.
|
200 | $50,328 | |
| 3 | PFE |
Pfizer Inc
|
1,820 | $43,825 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
579 | $33,361 | |
| 5 | JNJ |
Johnson & Johnson
|
72 | $18,285 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
10 | $11,994 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
24 | $3,032 | |
| 8 | OGN |
Organon & Co.
|
58 | $785 |
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,994 | 10 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||